医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Sample size re-estimation without un-blinding for time-to-event outcomes in oncology clinical trials

摘要Sample size re-estimation is essential in oncology studies.However,the use of blinded sample size reassessment for survival data has been rarely reported.Based on the density function of the exponential distribution,an expectation-maximization (EM) algorithm of the hazard ratio was derived,and several simulation studies were used to verify its applications.The method had obvious variation in the hazard ratio estimates and overestimation for the relatively small hazard ratios.Our studies showed that the stability of the EM estimation results directly correlated with the sample size,the convergence of the EM algorithm was impacted by the initial values,and a balanced design produced the best estimates.No reliable blinded sample size re-estimation inference can be made in our studies,but the results provide useful information to steer the practitioners in this field from repeating the same endeavor.

更多
广告
作者单位 Department of Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China [1] Department of Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China;Ministry of Education Key Laboratory for Modern Toxicology, School of Public Health, Nanjing Medical University,Nanjing, Jiangsu 211166, China [2]
栏目名称
发布时间 2018-03-13(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览10
  • 下载0
生物医学研究杂志(英文版)

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷